198 related articles for article (PubMed ID: 30232261)
1. Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.
Taracanova A; Tsilioni I; Conti P; Norwitz ER; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9381-E9390. PubMed ID: 30232261
[TBL] [Abstract][Full Text] [Related]
2. SP and IL-33 together markedly enhance TNF synthesis and secretion from human mast cells mediated by the interaction of their receptors.
Taracanova A; Alevizos M; Karagkouni A; Weng Z; Norwitz E; Conti P; Leeman SE; Theoharides TC
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4002-E4009. PubMed ID: 28461492
[TBL] [Abstract][Full Text] [Related]
3. Chondroitin sulfate inhibits secretion of TNF and CXCL8 from human mast cells stimulated by IL-33.
Gross AR; Theoharides TC
Biofactors; 2019 Jan; 45(1):49-61. PubMed ID: 30521103
[TBL] [Abstract][Full Text] [Related]
4. IL-33 stimulates human mast cell release of CCL5 and CCL2 via MAPK and NF-κB, inhibited by methoxyluteolin.
Bawazeer MA; Theoharides TC
Eur J Pharmacol; 2019 Dec; 865():172760. PubMed ID: 31669588
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.
Petra AI; Tsilioni I; Taracanova A; Katsarou-Katsari A; Theoharides TC
Allergy Asthma Proc; 2018 Mar; 39(2):153-160. PubMed ID: 29490771
[TBL] [Abstract][Full Text] [Related]
6. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
Theoharides TC; Zhang B; Kempuraj D; Tagen M; Vasiadi M; Angelidou A; Alysandratos KD; Kalogeromitros D; Asadi S; Stavrianeas N; Peterson E; Leeman S; Conti P
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4448-53. PubMed ID: 20160089
[TBL] [Abstract][Full Text] [Related]
7. Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells.
Patel AB; Theoharides TC
J Pharmacol Exp Ther; 2017 Jun; 361(3):462-471. PubMed ID: 28404689
[TBL] [Abstract][Full Text] [Related]
8. The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells.
Weng Z; Patel AB; Panagiotidou S; Theoharides TC
J Allergy Clin Immunol; 2015 Apr; 135(4):1044-1052.e5. PubMed ID: 25498791
[TBL] [Abstract][Full Text] [Related]
9. Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli.
Vasiadi M; Kalogeromitros D; Kempuraj D; Clemons A; Zhang B; Chliva C; Makris M; Wolfberg A; House M; Theoharides TC
Int Arch Allergy Immunol; 2010; 151(1):38-45. PubMed ID: 19672095
[TBL] [Abstract][Full Text] [Related]
10. Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.
Asadi S; Alysandratos KD; Angelidou A; Miniati A; Sismanopoulos N; Vasiadi M; Zhang B; Kalogeromitros D; Theoharides TC
J Invest Dermatol; 2012 Feb; 132(2):324-9. PubMed ID: 22089831
[TBL] [Abstract][Full Text] [Related]
11. Mercury induces inflammatory mediator release from human mast cells.
Kempuraj D; Asadi S; Zhang B; Manola A; Hogan J; Peterson E; Theoharides TC
J Neuroinflammation; 2010 Mar; 7():20. PubMed ID: 20222982
[TBL] [Abstract][Full Text] [Related]
12. Stimulated human mast cells secrete mitochondrial components that have autocrine and paracrine inflammatory actions.
Zhang B; Asadi S; Weng Z; Sismanopoulos N; Theoharides TC
PLoS One; 2012; 7(12):e49767. PubMed ID: 23284625
[TBL] [Abstract][Full Text] [Related]
13. Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
Kempuraj D; Tagen M; Iliopoulou BP; Clemons A; Vasiadi M; Boucher W; House M; Wolfberg A; Theoharides TC
Br J Pharmacol; 2008 Dec; 155(7):1076-84. PubMed ID: 18806808
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory cytokine IL-1beta stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis.
Kim GY; Lee JW; Ryu HC; Wei JD; Seong CM; Kim JH
J Immunol; 2010 Apr; 184(7):3946-54. PubMed ID: 20194723
[TBL] [Abstract][Full Text] [Related]
15. Substance P selectively activates TNF-alpha gene expression in murine mast cells.
Ansel JC; Brown JR; Payan DG; Brown MA
J Immunol; 1993 May; 150(10):4478-85. PubMed ID: 7683320
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells.
Castellani ML; Vecchiet J; Salini V; Conti P; Theoharides TC; Caraffa A; Antinolfi P; Teté S; Ciampoli C; Cuccurullo C; Cerulli G; Felaco M; Boscolo P
Transl Res; 2009 Jul; 154(1):27-33. PubMed ID: 19524871
[TBL] [Abstract][Full Text] [Related]
17. Silencing of H4R inhibits the production of IL-1β through SAPK/JNK signaling in human mast cells.
Ebenezer AJ; Prasad K; Rajan S; Thangam EB
J Recept Signal Transduct Res; 2018 Jun; 38(3):204-212. PubMed ID: 29863427
[TBL] [Abstract][Full Text] [Related]
18. Luteolin and thiosalicylate inhibit HgCl(2) and thimerosal-induced VEGF release from human mast cells.
Asadi S; Zhang B; Weng Z; Angelidou A; Kempuraj D; Alysandratos KD; Theoharides TC
Int J Immunopathol Pharmacol; 2010; 23(4):1015-20. PubMed ID: 21244751
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 secretion from human astrocytoma cells induced by substance P.
Gitter BD; Regoli D; Howbert JJ; Glasebrook AL; Waters DC
J Neuroimmunol; 1994 Apr; 51(1):101-8. PubMed ID: 7512575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
